Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors

Proceedings of the Society for Experimental Biology and Medicine

Volumn 211, Issue 4, 1996, Pages 366-373

  Miyamoto, Yoichi ^a,b   Akaike, Takaaki ^a   Yoshida, Masaki ^a   Goto, Shingo ^a   Horie, Hidechika ^a   Maeda, Hiroshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NOF Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; NITRIC OXIDE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; FEMALE; HYPERTENSION; MALE; NONHUMAN; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029875004     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-211-43982     Document Type: Article

References (40)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the regulation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980.
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269, 1987.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987.
4. Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349:326-328, 1991.
5. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
6. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87:10043-10047, 1990.
7. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275:87-90, 1990.
8. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-595, 1990.
9. G-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implication for the involvement of nitric oxide. Proc Natl Acad Sci USA 87:3629-3632, 1990.
10. Yoshida M, Akaike T, Wada Y, Sato K, Ikeda K, Ueda S, Maeda H. Therapeutic effect of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 202:923-930, 1994.
11. Kosaka H, Watanabe M, Yoshihara H, Harada N, Shiga T. Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon monoxide hemoglobin. Biochem Biophys Res Commun 184:1119-1124, 1992.
12. Blough NV, Zafiriou OC. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorg Chem 24:3502-3504, 1985.
13. - is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456, 1986.
14. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18:195-199, 1993.
15. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J 261:293-296, 1989.
16. •NO through a radical reaction. Biochemistry 32:827-832, 1993.
17. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266:4244-4250, 1991.
18. Klug-Roth D, Fridovich I, Rabani J. Pulse radiolytic investigation of catalyzed disproportionation. Mechanism for bovine superoxide dismutase. J Am Chem Soc 95:2786-2790, 1973.
19. Jarasch E-D, Grund C, Bruder G, Heid HW, Keenan TW, Franke WW. Localization of xanthine oxidase in mammarygland epithelium and capillary endothelium. Cell 25:67-82, 1981.
20. Jarasch E-D, Bruder G, Heid HW. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand (Suppl) 548:39-46, 1986.
21. AdachiT, Fukushima T, Usami Y, Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289:523-527, 1993.
22. Robins RK. Potential purine antagonists. I. Synthesis of some 4,6-substituted pyrazolo[3,4-d]pyrimidines. J Am Chem Soc 78:784-790, 1956.
23. Xanthine oxidase (milk). In: Worthington Enzyme Manual. Worthington Biochemical, Freehold, NJ, pp30-31, 1972.
24. Takahashi K, Akaike T, Sato K, Mori K, Maeda H. Superoxide anion generation by Pacific oyster (Crassostrea gigas) hemocytes: Identification by electron spin resonance spin trapping and chemiluminescence analysis. Comp Biochem Physiol 105B:35-41, 1993.
25. Cleland WW. Statistical analysis of enzyme kinetic data. Methods Enzymol 63:103-138, 1979.
26. Feigelson P, Davidson JD, Robins R. Pyrazolopyrimidines as inhibitors and substrates of xanthine oxidase. J Biol Chem 226:993-1000, 1957.
27. Robins RK, Revanker GR, O'Brein DE, Springer RH, Novinson T, Albert A, Senga K, Miller JP, Streeter DG. Purine analog inhibitors of xanthine oxidase - Structure-activity relationships and proposed binding of the molybdenum cofactor. J Heterocyclic Chem 22:601-634, 1985.
28. Nishino T, Schopfer LM, Massey V. The reactivity of chicken liver xanthine dehydrogenase with molecular oxygen. J Biol Chem 264:2518-2527, 1989.
29. Sato K, Akaike T, Suga M, Ando M, Maeda H. Generation of free radicals from neocarzinostatin mediated by NADPH/ cytochrome P-450 reductase via activation of enediyne chromophore. Biochem Biophys Res Commun 205:1716-1723, 1994.
30. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163, 1985.
31. - generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 85:739-745, 1990.
32. Maeda H, Akaike T. Oxygen free radicals as pathogenic molecules in viral diseases. Proc Soc Exp Biol Med 198:721-727, 1991.
33. Whitaker JR. Mechanisms of oxidoreductases. In: Richardson T, Finley JW, Eds. Chemical Changes in Food During Processing. New York: Van Nostrand Reinhold Company, pp121-176, 1985.
34. Massey V, Komai H, Palmer G, Elion GB. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines. J Biol Chem 245:2837-2844, 1970.
35. Nishino T, Tsushima K. The mode of inhibition of chicken liver xanthine dehydrogenase by pyrazolo[3,4-d]pyrimidines. Yokohama Med Bull 29:1-4, 1978.
36. G-monomethyl-L-arginine in SHR. Jpn J Pharmacol 54:461-463, 1990.
37. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88:10045-10048, 1991.
38. Kasten TP, Settle SL, Misko TP, Riley DP, Weiss RH, Currie MG, Nickols GA. Potentiation of nitric oxide-mediated vascular relaxation by SC52608, a superoxide dismutase mimic. Proc Soc Exp Biol Med 208:170-177, 1995.
39. Crow JP, Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity. In: Koprowski H, Maeda H, Eds. The Role of Nitric Oxide in Physiology and Pathophysiology. Current Topics in Microbiology and Immunology. Berlin: Springer-Verlag, Vol 196: pp57-73, 1995.
40. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, Maeda H. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996 (in press).